Nachrichten zur Boston Scientific Corp. Aktie

Heres Why You Should Add BSX Stock to Your Portfolio Now

Investors remain optimistic about Boston Scientific due to its geographical expansions and impressive MedSurg market share gain.…

BSX Stock Gains From FARAPULSE PFAs PMDA Approval in Japan

Boston Scientific achieves PMDA approval for its FARAPULSE PFA System in Japan. The company expects to launch the system in…

The S&P 500 to Hit 6,000 Soon? Buy 3 Momentum Stocks Now

S&P 500 stocks such as General Motors, Boston Scientific, and Assurant have been selected as the momentum picks for the…

NVIDIA & 2 Other S&P 500 Stocks Show Strong Earnings Growth

S&P 500 stocks such as NVIDIA, Boston Scientific and American Water Works are, currently, exhibiting superb earnings growth.…

BSX Gets FDA Nod on INGEVITY+ Pacing Lead in the LBBA: Stock to Gain?

Boston Scientific received FDA approval on the expanded indication for INGEVITY+ Pacing Leads. Data demonstrated this lead to be safe…

Boston Scientifics ACURATE Prime Aortic Valve System Wins CE Mark

BSX achieves CE Mark approval for the ACURATE Prime Aortic Valve System, its latest TAVR technology.…

Boston Scientific (BSX), Silk Road Merger Delayed for Review

Boston Scientific (BSX) withdraws its premerger notification and report form to give the U.S. FTC more time to review the…

3 Profitable S&P 500 Stocks With Room to Run: NOW, BSX, COO

ServiceNow (NOW), Boston Scientific (BSX) and The Cooper Companies (COO) have been selected as the top picks with a high…

The Zacks Analyst Blog Highlights Amazon, Boston Scientific, Shopify and Cooper-Standard

Amazon, Boston Scientific, Shopify and Cooper-Standard are included in this Analyst Blog.…

Is It Worth Investing in Boston Scientific (BSX) Based on Wall Streets Bullish Views?

Based on the average brokerage recommendation (ABR), Boston Scientific (BSX) should be added to ones portfolio. Wall Street analysts overly…

Boston Scientific (BSX) Rides on Global Growth, Buyouts

Boston Scientifics (BSX) Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of GI and…

Boston Scientific (BSX) Q2 Earnings Beat, Organic Sales Rise

Boston Scientific (BSX) registers a strong year-over-year improvement in sales, indicating solid market share gains in legacy businesses across all…

Boston Scientific (BSX) Banks on Global Expansion, Innovation

In EMEA, Boston Scientific (BSX) is successfully expanding its base, banking on its diverse portfolio, new launches and commercial execution…

Boston Scientific Q2 Earnings Preview: Can The Rally Continue?

…

Will WATCHMAN Sales Aid Boston Scientifics (BSX) Q2 Earnings?

In EMEA, Boston Scientific (BSX) is expected to have registered growth within structural heart, including Transcatheter aortic valve replacement, WATCHMAN…

Boston Scientific (BSX) DBS Programming Software Gets CE Mark

Boston Scientific (BSX) secures CE Mark for the DBS image-guided programming software, Vercise Neural Navigator 5.…

Zacks Industry Outlook Highlights Boston Scientific, ResMed, Lantheus and Haemonetics

Boston Scientific, ResMed, Lantheus and Haemonetics are part of the Zacks Industry Outlook article.…

Boston Scientific Acquires Silk Road Medical: Unveiling Investor Implications

…

Boston Scientific (BSX) to Buy Silk Road, Boost Cardiology

This acquisition is expected to enhance Boston Scientifics (BSX) market position and revenue streams in North America and Europe.…

Silk Road Medical to be acquired by Boston Scientific, shares surge 24% By Investing.com

Silk Road Medical to be acquired by Boston Scientific, shares surge 24%…

Boston Scientific to Buy Silk Road Medical for About $1.26 Billion

…

Boston Scientific to buy Silk Road Medical in $1.16 billion deal By Reuters

Boston Scientific to buy Silk Road Medical in $1.16 billion deal…

Silk Road Medical Announces Definitive Agreement to be Acquired by Boston Scientific

Boston Scientific to acquire Silk Road Medical for $27.50 per share in cash…

Boston Scientific Has Become A Standout Growth Story In Med-Tech

…

Minimaler Kursabschlag bei der Boston Scientific-Aktie (68,9964 €)

Der Kurs der der Aktie von Boston Scientific kommt kaum von der Stelle. Das Wertpapier kostete zuletzt 74,83 US-Dollar. Kaum…

Heres Why You Should Buy Boston Scientific (BSX) Stock Now

Investors continue to be optimistic about Boston Scientific (BSX) due to its geographical expansions and impressive acquisitions.…

Boston Scientific (BSX) Rides on Emerging Markets, MedSurg

Boston Scientifics (BSX) Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of GI and…

Boston Scientific (BSX) Reaches 52-Week High: Whats Aiding It?

Investors are optimistic about Boston Scientifics (BSX) impressive market share gain in the MedSurg segment and continued geographical expansion.…

Boston Scientific (BSX) mCRM System Study Outcome Favorable

Boston Scientific (BSX) mCRM System is designed to communicate wirelessly and coordinate painless intracardiac anti-tachycardia pacing (ATP) therapy.…

Boston Scientific succeeds in pivotal trial for leadless pacemaker

…

Boston Scientific (BSX) Gains From MedSurg Growth & Buyouts

Within Neuromodulation, Boston Scientifics pain business is consistently gaining traction, banking on strength in the spinal cord stimulation (SCS) business.…

Top Analyst Reports for Boston Scientific, Arista Networks & Palo Alto Networks

Todays Research Daily features new research reports on 16 major stocks, including Boston Scientific Corporation (BSX), Arista Networks, Inc. (ANET)…

Investing in Cardiovascular MedTech Companies

Cardiovascular diseases remain the leading global cause of death, taking an estimated 17.9 million lives annually, based on data from…

Boston Scientific pipeline strength fuels quarterly earnings beat By Investing.com

Boston Scientific pipeline strength fuels quarterly earnings beat…

Boston Scientific (BSX) Q1 Earnings Beat Estimates, View Raised

Barring Neuromodulation, organic and operational revenues at Boston Scientifics (BSX) core business segments rise in the first quarter.…

Boston Scientific Q1 2024 Earnings Preview

…

Stryker auf "Tactical Outperform"-Liste gesetzt - Aktienanalyse

New York (www.aktiencheck.de) - Stryker-Aktienanalyse von Evercore ISI: Die Analysten von Evercore ISI stufen die Aktie von Stryker Corp. (ISIN: US8636671013,…

Whats in Store for Boston Scientific (BSX) in Q1 Earnings?

Boston Scientific (BSX) is expected to have registered strong growth in the Asia Pacific, led by strength in China, Japan…

Aktie von Boston Scientific: Kurs mit wenig Bewegung (63,6701 €)

CODE Der jüngste Kurs betrug 68,40 US-Dollar. Kaum verändert im Vergleich zu der Schlussnotierung vom Vortag zeigt sich derzeit der…

Boston Scientific (BSX) Faces Rising Costs, Competition

With Boston Scientific (BSX) recording 40% of its sales from the international market, it remains highly exposed to currency fluctuations.…

Investing in Boston Scientific (NYSE:BSX) five years ago would have delivered you a 82% gain

Passive investing in index funds can generate returns that roughly match the overall market. But in our experience...…

Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash

…

Boston Scientific merger with Axonics faces FTC scrutiny By Investing.com

Boston Scientific merger with Axonics faces FTC scrutiny…

Boston Scientific/Axonics merger to close in 2H24 as FTC seeks more info on $3.7B deal

…

Boston Scientific EVP Wendy Carruthers sells $477,776 in stock By Investing.com

Boston Scientific EVP Wendy Carruthers sells $477,776 in stock…

Boston Scientific: The Markets Newest Mega-Cap Needs A Breather

…

Boston Scientific (BSX) and Scivita Medical Expand Partnership

Boston Scientific (BSX) and Scivita Medical announce an expanded strategic cooperation arrangement.…

Scivita Medical broadens ties with Boston Scientific By Investing.com

Scivita Medical broadens ties with Boston Scientific…

Boston Scientific (BSX) Global Growth Robust, Macro Issues Ail

Boston Scientific (BSX) is consistently registering fast recovery within its MedSurg segment in the post-pandemic period.…

Axonics ticks higher as Boston Scientific reiterates close in 1H24

…